Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050172-26-000028 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 14, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
48,426
Total Value
$613,820.53
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D&CMO | Common Stock | โ | Aug 13, 2026 | Exercise/Conversion | 16,142 | $10.42 | $168,199.64 | 16,142 | Direct | โ | View Details | |
President, R&D&CMO | Common Stock | โ | Aug 13, 2026 | Sale | 16,142 | $27.61 | $445,620.89 | 0 | Direct | โ | View Details | |
President, R&D&CMO | Stock Option (Right to Buy) | Derivative | Aug 13, 2026 | Exercise/Conversion | 16,142 | $0.00 | $0.00 | 176,803 | Direct | โ | View Details |